48,448
edits
Difference between revisions of "Myeloproliferative neoplasms"
Jump to navigation
Jump to search
Myeloproliferative neoplasms (view source)
Revision as of 03:46, 29 November 2011
, 03:46, 29 November 2011fix sp.
(wikify) |
(fix sp.) |
||
| Line 6: | Line 6: | ||
They include the following:<ref name=pmid15781101>{{cite journal |author=Baxter EJ, Scott LM, Campbell PJ, ''et al.'' |title=Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders |journal=Lancet |volume=365 |issue=9464 |pages=1054–61 |year=2005 |pmid=15781101 |doi=10.1016/S0140-6736(05)71142-9 |url=}}</ref> | They include the following:<ref name=pmid15781101>{{cite journal |author=Baxter EJ, Scott LM, Campbell PJ, ''et al.'' |title=Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders |journal=Lancet |volume=365 |issue=9464 |pages=1054–61 |year=2005 |pmid=15781101 |doi=10.1016/S0140-6736(05)71142-9 |url=}}</ref> | ||
*Polycythemia vera. | *Polycythemia vera. | ||
*Essential | *Essential thrombocythemia. | ||
*Idiopathic myelofibrosis. | *Idiopathic myelofibrosis. | ||